Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/19/19 → 8/31/50 |
Funding
- Northwestern University
- Janssen Research & Development, LLC
PROTOSTAR CNTO1959PSO3011: A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in
- Paller, Amy (PD/PI)
Project: Research project